Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Norovirus” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Norovirus market,…
Clinical-development joint venture commended for staff growth and retention WILMINGTON, N.C. & TOKYO–(BUSINESS WIRE)–PPD-SNBL, the joint venture of Pharmaceutical Product…
IASO Biotherapeutics unveils an innovative new CAR-T therapy for the treatment of relapse/refractory multiple myeloma and the retreatment of previously…
DUBLIN–(BUSINESS WIRE)–The “HPLC Systems and Accessories: Global Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. This…
One of CARsgen Therapeutics’ leading drug candidates, CT053 fully human BCMA (B-Cell Maturation Antigen)-CAR-T cell for the treatment of patients suffering from relapsed/refractory multiple myeloma (rrMM), has received Investigational New Drug (IND) clearance from the United States Food and Drug Administration (FDA).
Japanese Ministry of Health, Labour, and Welfare has granted a second manufacturing and marketing approval for Myriad Genetics’ subsidiary, Myriad Genetic Laboratories, for BRACAnalysis Diagnostic System as a companion diagnostic with the PARP inhibitor, Lynparza, marketed by AstraZeneca and Merck.
Liquid biopsy assay with recent Breakthrough Device Designation from FDA is being used to screen patients with prostate cancer for…
MONTREAL–(BUSINESS WIRE)–#HR–BIOQuébec and BioTalent Canada have announced a collaboration agreement to facilitate access to human resources services specific to life…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…
It is estimated that there were approximately 92.2
million prevalent cases of uterine fibroids worldwide in females aged
15 years and over, and forecasts that number to increase to 102.7
million prevalent cases by 2026.